From: Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity
Active BD
Inactive BD
Controls
P
CD45RO-CD27+ (%)
7.5 ± 2.25
24 ± 7
28 ± 8
< 0.0001
CD45RO+CD27+ (%)
11 ± 6.44
47 ± 9
49 ± 9
CD45RO+CD27- (%)
57 ± 13
17.8 ± 9.7
19.2 ± 6.7
< 0.001
CD45RO-CD27- (%)
20 ± 6
8.6 ± 3.8
5.5 ± 5.5